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In recent decades, the pervasiveness of increased arterial stiffness in patients with
cardiovascular disease has become increasingly apparent. Though, this phenomenon
has been well documented in humans and animal models of disease for well over
a century, there has been surprisingly limited development in a deeper mechanistic
understanding of arterial stiffness. Much of the historical literature has focused on
changes in extracellular matrix proteins—collagen and elastin. However, extracellular
matrix changes alone appear insufficient to consistently account for observed changes in
vascular stiffness, which we observed in our studies of aortic stiffness in aging monkeys.
This led us to examine novel mechanisms operating at the level of the vascular smooth
muscle cell (VSMC)—that include increased cell stiffness and adhesion to extracellular
matrix—which that may be interrelated with other mechanisms contributing to arterial
stiffness. We introduce these observations as a new concept—the Smooth Muscle
Cell Stiffness Syndrome (SMCSS)—within the field of arterial stiffness and posit that
stiffening of vascular cells impairs vascular function and may contribute stiffening to the
vasculature with aging and cardiovascular disease. Importantly, this review article revisits
the structural basis of arterial stiffness in light of these novel findings. Such classification
of SMCSS and its contextualization into our current understanding of vascular mechanics
may be useful in the development of strategic therapeutics to directly target arterial
stiffness.
Keywords: cell stiffness, atomic forcemicroscopy, aorta, vascular smoothmuscle cells, cell biology, cytoskeleton,
collagen, elastin
INTRODUCTION
Increased arterial stiffness is a significant consequence of the natural aging process, but it is
also associated with the presence of underlying cardiovascular disease. As such, an increase in
aortic stiffness is frequently observed in populations with hypertension, obesity and diabetes.
Additionally, gender also plays a role in the manifestation of increased arterial stiffness, as women
may be more vulnerable to its deleterious effects. Altogether, it is increasingly apparent that there
is significant clinical value in assessing and fully understanding the phenomenon of increased
vascular stiffness. A deeper understanding of the underlying mechanisms may help motivate future
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development of effective strategies to combat increased vascular
stiffness by targeting novel cellular mechanisms and minimize
associated cardiovascular disease risks.
While the topic of vascular stiffness has been previously
reviewed, in this analysis, we focus on describing how
cellular mechanics may contribute to the structural basis of
increased arterial stiffness. In this review, we consider individual
components of the vascular wall, and briefly present a literature
survey to discuss current concepts of how thesemay contribute to
vascular stiffness.We also emphasize in this review new reports of
a stiff cellular phenotype that appears to impact endothelial cells
(EC) and, as we have recently observed, vascular smooth muscle
cells (VSMC). For VSMC, our work has demonstrated that there
is a significant increase in the VSMC stiffness and adhesion to
the extracellular matrix (ECM) - that occurs in conjunction with
increased vascular stiffness. We hypothesize that this cellular
level stiffening alters vascular function and contributes to the
changes observed in vascular stiffening observed in aging and
cardiovascular disease, which we term the “Smooth Muscle Cell
Stiffness Syndrome.” Although, syndrome is technically defined
as a group of symptoms that consistently occur together, we are
using this term to describe the concurrence of vascular smooth
muscle stiffness within the broader field of vascular stiffness.
We believe that understanding the mechanisms that underlie
this Syndrome will provide new clues to help improve our
understanding and therapeutic targeting of increased vascular
wall stiffness.
EPIDEMIOLOGY OF ARTERIAL STIFFNESS
Changes in the mechanical properties of the vasculature are co-
morbid with cardiovascular disease. Clinical studies have directly
linked increased arterial stiffness to several risk factors for
cardiovascular diseases—including hypertension (Avolio et al.,
1985; Nichols et al., 1993; Tomiyama et al., 2004; Mitchell et al.,
2010), aging (Newman and Lallemand, 1978; Franklin et al.,
1997; Tomiyama et al., 2003; Matsuoka et al., 2005; Mitchell
et al., 2007; AlGhatrif et al., 2013), atherosclerosis (van Popele
et al., 2001; Gepner et al., 2014), obesity (Fu et al., 2013; Pal
and Radavelli-Bagatini, 2013), diabetes (Shen et al., 2013; Shimizu
et al., 2013), kidney disease (Baumann et al., 2014), andmetabolic
syndrome (Scuteri et al., 2014). In addition, there is evidence that
increased aortic stiffness in woman is particularly predictive of
eventual cardiovascular disease, and that women may be more
vulnerable to the pathology associated with increased arterial
stiffness (Scantlebury and Borlaug, 2011; Laurent et al., 2012a;
Coutinho et al., 2013; Ben-Shlomo et al., 2014). There is a
growing support for the concept that arterial stiffness is a good
predicative biomarker for cardiovascular disease and risks (Vogel
and Benitez, 2000; Anderson, 2006; Franklin, 2007; Laurent and
Boutouyrie, 2007; Martin et al., 2008; Wang et al., 2008; Laurent
et al., 2012a,b). Therefore, increased arterial stiffness should be
considered as a biomarker central to aging and cardiovascular
disease.
It is also well established that the presence of multiple
cardiovascular risk factors may interact with and exacerbate
increases in arterial stiffness. For example, there is considerable
epidemiological evidence to suggest that hypertension accelerates
the process of arterial stiffening in aging (Tomiyama et al.,
2004; European Society of Cardiology, 2010; Verwoert et al.,
2014). However, it has been controversial whether the risk factors
directly cause the increase in arterial stiffness, or whether the
increased vascular stiffness exacerbates the disease state, such as
has been analyzed in the case of hypertension (Mitchell, 2014).
Notably, a recent Framingham study found increased arterial
stiffness precedes hypertension (Kaess et al., 2012), and this has
supported the concept that arterial stiffness is not necessarily
caused by hypertension but may be a good predictor of risk
for hypertension development and its subsequent complications
(Boutouyrie et al., 2002; Laurent et al., 2003; Tomiyama et al.,
2013). It has also been conjectured that the presence of arterial
stiffness may complicate the management of cardiovascular
disease. For example, in patients with increased arterial stiffness,
blood pressure is more difficult to control, as arterial stiffness
is also associated with resistant hypertension (Pabuccu et al.,
2012). However, the identity of the interactive mechanisms
associated with arterial stiffness and cardiovascular risk factors
remains unclear and may involve any number of environmental
components within the vascular wall, such as mechanical stimuli,
endothelial derived and inflammatory cytokines and changes in
the properties of the ECM. Continued research is warranted
to investigate the underlying mechanisms of arterial stiffness in
cardiovascular disease, and how they interact with each other, as
well as how systemic disease mechanisms influence the process of
arterial stiffening.
PATHOPHYSIOLOGY OF ARTERIAL
STIFFNESS
Vascular stiffness is considered a major health problem because
it affects not only arterial pressure and is a cause of
systolic hypertension and stroke, but also affects regulation of
vascular resistance and blood flows to important regional beds
including the coronary, renal and cerebral, which have obvious
consequences when compromised. As discussed above, increased
vascular stiffness is observed in many disease states, e.g.,
atherosclerosis, hypertension and diabetes, but it is important to
note that it is most commonly found associated with aging. It is
currently held that all elderly individuals suffer from increased
vascular stiffness to a more or less degree. It is generally not
recognized that vascular stiffness increases from fetal gestation
to newborn to adults, even before the aging process begins
(Pagani et al., 1979). The problem of increased vascular stiffness
has been recognized for centuries, but techniques to assess its
severity have changed. The most commonly used technique
comes from autopsy and in vitro assessment of stiffness. In vitro
measurements of stiffness are still widely employed. However,
in vivo, techniques have also been applied. Most commonly
finding increased systolic arterial pressure and a widened pulse
pressure are used as indicators of increased aortic stiffness.
More recently, with the advent of echo/ultrasound and MRI
assessment of vascular dimensions, these techniques have been
employed both in animal and human experiments to assess
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vascular stiffness. For many experiments in animals, anesthesia
and recent surgery are required for these measurements, which
by itself, has a major impact on vascular stiffness. Furthermore,
the echo and MRI techniques have often only been used to
obtain snapshots of vascular stiffness, not beat-to-beat changes.
To obviate these problems, we developed techniques to measure
vascular stiffness instantaneously and continuously in conscious
animals without the complicating influences of recent surgery
or anesthesia. To do this, ultrasonic crystals are implanted on
opposing surfaces of the aorta and a pressure gauge is implanted
in the aorta to provide beat by beat measurements of arterial
pressure and diameter, which are critical for assessing stiffness
(Pagani et al., 1978, 1979; Vatner et al., 1980). We have used
these techniques for studies inmonkeys, dogs, adult and newborn
and fetal sheep (Pagani et al., 1978, 1979, 1980; Vatner et al.,
1980, 1984; Macho and Vatner, 1981; Qiu et al., 2007, 2010) to
overcome the limitations of other technical approaches.
It is clear that the pathophysiologic influence of increased
arterial stiffness on the cardiovascular system is multifactorial.
One major consequence of increase aortic stiffness is a
diminished Windkessel effect within the cardiovascular system.
First proposed by Frank in 1899, the Windkessel model reduces
the vascular system into capacitance and resistance elements
(Sagawa et al., 1990). In essence, the large arteries are functionally
characterized as a capacitor or reservoir for ejected blood before
it can by fully conducted through smaller resistance vessels. The
aorta distends outwards to accommodate the surge in blood
volume after it is ejected from the heart during systole, and
subsequently recoils inward during diastole to continue to propel
blood distally. This capacitive property of the aorta also extends
the pressure gradient (as after the aortic valve closes, there is
no upstream cardiac-facilitated pressure gradient) that aids in
propelling the blood forward.
In addition, this capacitive behavior of the aortic wall also
absorbs some of the energy during ejection and dampens the
rise in systolic pressure thus modulating pulse pressure. As such,
increased arterial stiffness also decreases the ability of the aorta
to dampen the pressure pulse. The aorta normally acts to cushion
the pressure pulse created by the ejected blood by absorbing
energy. In doing so it acts to transform the ejected pulsatile flow
into a more steady flow pattern as blood enters smaller vessels
and downstream tissues. In the presence of increased stiffness
of the aorta there is a diminished ability of the aorta to absorb
energy following ejection and thus to diminish the amplitude of
the pulse pressure and the transmitted arterial pressure wave.
Consequently, an aorta with increased stiffness will exhibit a
decrease in mechanical compliance, a diminished capacitance for
ejected blood, less absorption of energy on ejection and result
in a higher systolic pressure. This leads to an increased pulse
pressure and deeper penetration of the pulse pressure wave into
the peripheral vasculature. Frequently, increased arterial stiffness
is associated with microvascular remodeling and impaired tissue
blood flow autoregulation, eventually leading to end organ
damage, which can be of particular clinical significance when the
coronary, renal or cerebral circulations are impaired (Pessina,
2007; Safar and Lacolley, 2007; Mitchell, 2008; van den Akker
et al., 2010). The role of the increase in pulse pressure in these
microvascular changes and ultimate end organ damage requires
further attention.
Finally, increased arterial stiffness is also damaging because it
increases the workload on the heart. This increase in workload
is derived from concepts concerning the importance of reflected
waves within the arterial system (O’Rourke and Yaginuma, 1984;
Latham et al., 1985; Nichols and Edwards, 2001). For every
forward traveling pressure wave away from the heart, there
a partially reflected pressure wave that travels backwards to
the heart. A reflected wave is produced at sites of impedance
discontinuity in the vascular system, which are typically
occurring at branching points and high resistance/smaller caliber
vessels (Nichols et al., 2005). Under normal conditions, the
mechanical properties of the aorta are such that the return
of the reflected wave occurs during diastole. This timing
is physiologically beneficial to the heart since the coronary
arteries are filled during diastole and as such the reflected wave
contributes to enhanced filling of the coronary arteries. However,
in an aorta characterized by increased stiffness, the reflected
wave travels faster and reaches the heart during systole. This
has the dual-fold effect of increasing afterload/workload and
effectively and can lead to decreased stroke volume. Secondly,
the mismatched timing of the return of the reflected wave
with diastole decreases coronary artery perfusion. Numerous
epidemiological studies have found an association between
increased pulse wave reflection and cardiovascular disease
(London et al., 2001; Nürnberger et al., 2002; Mitchell et al.,
2004; van Trijp et al., 2004; Hashimoto et al., 2008; Nichols et al.,
2013). Thus, the increase in aortic stiffness has an impact on
both cardiac function and potentially important effects on the
microcirculation and end organ functions.
ARTERIAL STIFFNESS, A NOVEL TARGET
FOR THERAPEUTIC CONTROL
Targeting arterial stiffness per se for therapeutic control
represents a new avenue of cardiovascular disease. The concept of
focusing directly on controlling vascular stiffness has its origins
largely derived from studies by O’Rourke et al. on the control
of hypertension (O’Rourke, 1985, 1989, 1990a,b, 1992; Avolio
et al., 1986). The principle strategy has been utilization of existing
antihypertensive therapies to control arterial stiffness (Safar
et al., 1988). As previously reviewed by Benetos and colleagues,
several classes of anti-hypertensive drugs—ACE inhibitors,
calcium channel blockers, nitrates—have been demonstrated
to have beneficial side-effects that include diminishing arterial
stiffness (Benetos et al., 1997). However, these therapeutics
were developed to decrease mean arterial pressure (MAP) by
controlling total peripheral resistance (through acting as a VSMC
relaxant), cardiac output, heart rate and blood volume, and
thereby the effect on arterial stiffness is indirect and was not
specifically targeted. The effectiveness of these drugs is, notably,
varied, and still under evaluation (Briet and Schiffrin, 2013;
Laurent and Boutouyrie, 2014; Peters et al., 2014).
Importantly, the selective use of anti-hypertensives to
attempt to modulate arterial stiffness may not be adequate
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for all patients. For example, elderly patients often present
with a decrease in diastolic pressure. This is an important
therapeutic consideration, as the dosage for treatment with
anti-hypertensives should only be administered to the point
where diastolic pressure does not decrease below 70mmHg
(Kaplan, 2000). Thus, continuing to look at treatments that show
increased selectivity for altering vascular stiffness would hold
great potential. Moreover, the variability when comparing the
effects of anti-hypertensive drugs on vascular stiffness suggests
the presence of other unidentified mechanisms underlying
arterial stiffness. Thus, a new generation of therapeutics that can
selectively target arterial stiffness and control pulse pressure (PP),
instead of the control of MAP may be of considerable value.
Further, study in the identification of potential therapeutic targets
to control arterial stiffness is warranted.
MAJOR MECHANISMS MEDIATING
CAUSES OF INCREASED VASCULAR
STIFFNESS
Aging and Gender Considerations
As noted above the most common etiology of increased stiffness
is aging. Most of the literature on this topic has used either
human models of aging or animal models, most frequently
rodents. Each of these have an inherent problem for aging
studies. In aged humans, it is difficult to study the isolated
effects of increased stiffness in the absence of some degree of
atherosclerosis. We studied Fascicularis and Rhesus monkeys as
young adults (3–7 years old) and after aging (over 20 years old).
We found that aortic stiffness increased, but much more in old
males than females (Figure 1), consistent with what is known
in aging humans, where older females, before menopause, are
protected frommost cardiovascular diseases. Our data (Figure 1)
and recent studies (Takagi et al., 2003; Qiu et al., 2007, 2010)
demonstrate that there are major gender differences in aging
monkeys, and that there are major differences in the expression
of genes and proteins regulating vascular function that are
evident even between young male and female monkeys (Qiu
et al., 2007). Some prior studies have also found that older
females are relatively protected from vascular stiffness (Jonason
et al., 1997), and that this protection disappears after menopause
(Waddell et al., 2001). Importantly, the physiology of female
nonhuman primates is very similar to that of women in terms
of reproductive adaptation to aging, including hormone profiles
during the menopausal transition, extent of age-related and
menopause-associated effects of changes in hormone levels on
metabolism, bone loss, and impaired cardiovascular function
FIGURE 1 | (A) Aortic stiffness increased in old males and females compared to younger monkeys. However, aortic stiffness was increased more in old males than
old females. (B) There was little significant difference in collagen density in those groups. (C) Elastin density was decreased more in old males than the females.
(D) The collagen/elastin ratio increased more in old males than old females. Reprinted from Qiu et al. (2007). *P < 0.05 vs. corresponding young animals; †P < 0.05
vs. corresponding old male monkeys.
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(Rodgers et al., 1993; Walker et al., 1995; Gilardi et al., 1997; Qiu
et al., 2007). The similarities also include the shifts in hormonal
profiles through the menopausal transition, the progression to
cycle termination through irregular cycles, and the protective
responses to estrogen replacement following oophorectomy
(Gilardi et al., 1997; Shideler et al., 2001; Cline and Wood, 2005).
The use of rodents for these research purposes is limited by
the fact that rodents do not have menstrual cycles and exhibit
periods of persistent estrous, which is associated with elevated
and constant levels of estrogen, low levels of progesterone, and a
lack of luteinizing hormone surges (Felicio et al., 1984; Wu et al.,
2005).
Extracellular Matrix
The most common mechanism thought to mediate increased
vascular stiffness involves remodeling and content changes in the
ECM of the aorta, with increases in collagen and decreases in
elastin. Many studies can be found dealing with the structural
content and properties of ECMproteins, predominantly collagen,
elastin and fibronectin. Elastin is highly abundant in large and
small arteries and in the aorta confers distensibility to account for
the recoil ability of the aorta. At low mechanical loads, vascular
mechanical properties are predominantly determined by elastin
fibers. At these loads, collagen fibers have been histologically
shown to have a loose, wavy configuration suggesting that they
are not load-bearing. Upon higher mechanical loads, mechanical
force transfers to the collagen fibers and they can be observed to
straighten and lose their wavy appearance suggestive of bearing
greater loads and thus contributing to a larger degree to the
mechanical properties of the vessel. These relative mechanical
contributions of elastin and collagen are thought responsible for
the characteristic stress-strain curve of the arterial wall. Increased
arterial stiffness has thus been proposed to be associated with
increases in collagen content that occur concomitantly with
decreases in elastin content. Numerous studies of aging vessels
have reported increases in the collagen/elastin content ratio,
and have associated this conclusion with the increase in arterial
stiffness with aging. In fact, this view of increased collagen and
decreased elastin has dominated thinking in the field of arterial
stiffness to the point that it has become conceptually dogmatic.
However, an in depth analysis of published studies of
hypertension strongly suggest that this view of an increased
collagen to elastin ratio may not be entirely accurate. Several
reports have demonstrated a lack of increased collagen in
hypertension (Bezie et al., 1998a; Koffi et al., 1998, 1999; van
Gorp et al., 2000; Sehgel et al., 2015), with some reporting
decreases in vascular collagen (Cox, 1981; Mizutani et al., 1999).
These stand in contrast to studies of hypertension that report
observations of increased vascular collagen (Mourlon-Le Grand
et al., 1993; Koffi et al., 1998, 1999), in a similar fashion as
reported in studies of aging. A time-course study by Hu and
colleagues found aortic collagen increased initially following
induction of hypertension, but the concentration returned to
levels not different from the sham control in the long-term
(Hu et al., 2008). The inconsistency in the literature may reflect
contributions from numerous variables between studies. For
example, discrepancies in the quantification of arterial collagen,
the models of hypertension used, the stage at which hypertension
was studied and the precise vascular sites that were harvested
for investigation (Sehgel et al., 2015). Importantly, studies of
human essential hypertension, which assessed vascular collagen
post-mortem, found that the collagen content was unchanged
with hypertension (Schlatmann and Becker, 1977; Hoshino et al.,
1995) or to have a similar concentration (Faber and Oller-Hou,
1952) compared to age-matched normotensive patients.
The rationale for examining mechanisms for increased
vascular stiffness, apart from the extracellular matrix, at the level
of VSMC was derived from our aging monkey studies where we
observed no change in collagen density, but decreases in elastin
were more marked in old males than old females (Figure 1).
Below we review a number of the major causes that have been
implicated as contributing to increased vascular stiffness. In
reviewing these mechanisms we were surprised by the lack of
consistent changes among various studies and that often there
were no changes in collagen density. We hypothesized that the
changes in elastin density were insufficient to cause such major
changes in aortic stiffness. This led us to look for other causes
of increased vascular stiffness resulting in our novel concept
of increased stiffness at the level of individual vascular smooth
muscle cells.
Concept of Increased Vascular Smooth
Muscle Cells (VSMC) Stiffness
Although, as discussed, there are several components of the
vessel wall that might induce and contribute to increased vascular
stiffness. We have recently focused on the isolated VSMC from
aging primates and used AFM to measure the stiffness of these
isolated cells. Of relevance to this topic, we found that there was
a major increase in VSMC stiffness (Figure 2). We then went
on to study hypertension in SHR rats and confirmed that this
mechanism is important for mediating increased stiffness, not
only in aging, but also in hypertension (Figure 3).
Overall, there has been limited information available as to
the contribution of VSMC to arterial stiffness and vessel wall
mechanics. VSMC are the predominant cell type within the
arterial wall, and in large arteries are estimated to account for 25–
35% of total volume (Nichols et al., 2005). They play a critical
role in regulation vascular tone that may impact importantly
upon hypertension. In large arteries, VSMC are also responsible
for buffering pressure pulsatility. Under chronic conditions,
they respond to increased mechanical stress by undergoing
hypertrophy (Li and Xu, 2000). Additionally, VSMC may also
undergo a phenotypic switching from a quiescent contractile
phenotype to a proliferative secretory phenotype. Recently, it has
been suggested that VSMC may also dedifferentiate to a more
osteogenic phenotype, and thereby may play a role in increasing
stiffness through vascular calcification (Pikilidou et al., 2015). It
is plausible that VSMC may play a larger role in contributing to
vascular wall stiffness and arterial wall mechanics than previously
considered.
However, a major limitation to investigations of VSMC
contributions to arterial stiffness has been technical limitations
associated with its independent measurement. There is the
generally accepted assumption that the contribution of VSMC to
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FIGURE 2 | Mechanical properties of single VSMC measured by AFM. (A) Distribution of force as a function of indentation in young (pink) (n = 40 cells) and old
(blue) (n = 76 cells) monkeys. Increased cell stiffness is evident as higher force requirement for indentation. (B) VSMC stiffness 4 fold increased in old vs. young
monkeys. *P < 0.05 vs. young monkeys. Reprinted from Qiu et al. (2010).
FIGURE 3 | Hypertension in spontaneously hypertensive rats (SHR) vs. Wistar-Kyoto (WKY) rats (A) was associated with increased aortic stiffness,
measured by pulse wave velocity (B) and stiffness was also increased in individual vascular smooth muscle cells (VSMCs), as determined by atomic
force microscopy measurements (C). *P < 0.05, compared to WKY. Reprinted from Sehgel et al. (2013).
vessel wall stiffness is related to the degree of active tone in the
cell, which will stiffen the cell. However, an alternative possibility
is that there may be more chronic changes in the inherent
mechanical properties of VSMC themselves, independent of
contractile tone, that lead to stiffening of the cell itself. For
example, a change in the expression and elastic stiffness of the
cellular cytoskeletal components that may in turn play a role in
the stiffness of the vascular wall. There is abundant evidence to
demonstrate that stiffness is an important functional property
inherent to all cell types-both contractile and non-contractile
(Schaer-Zammaretti and Ubbink, 2003; Defranchi et al., 2005;
Lekka et al., 2005; Oberleithner, 2005; Trache et al., 2005; Cross
et al., 2008; Wu et al., 2010; Barry et al., 2015).
Using a specialized type of nanotechnology, AFM, we have
recently reported the novel observation that intrinsic stiffness
of VSMC is increased in association with increased aortic
stiffness (Qiu et al., 2010; Zhu et al., 2012; Sehgel et al., 2013,
2015). This was accomplished using AFM probes to directly
nanoindent the VSMC cell surface to permit estimation of the
cell elastic modulus. The observed increase in VSMC stiffness
was observed in resting cells independent of application of
contractile agonists and was consistently found in several models
exhibiting increased aortic stiffness: aging primates, hypertensive
rats (spontaneously hypertensive rats (SHR)), and aging rats
with and without hypertension. The increase in stiffness is
accompanied by observable changes in the cytoskeletal features
of the aged cells (Figure 4). We also noted the presence of
increased stiffness in VSMC and overall vascular stiffness in
aged rats without hypertension, supporting that increased VSMC
stiffness reflects a feature of the aging vascular vasculature
stiffness independent of arterial pressure (Sehgel et al., 2015).
Collectively, the results of these studies strongly indicate that
VSMC stiffness may be an important component of the increased
vascular stiffness condition. Collectively, these observations point
to the importance of developing a deeper understanding of
factors and mechanisms that regulate cell stiffness in VSMC and
how increased cellular stiffness affects VSMC function.
Of potential importance we observed that the stiffness
of VSMC is a dynamic property, and it was observed to
oscillate with time (Zhu et al., 2012; Sehgel et al., 2013).
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FIGURE 4 | Contact mode height image (top) for a typical old and young monkey aortic VSMC. The height image data was pseudo- colored and slightly tilted
to enhance relief contrast. The images reveal an extensive network of actin filaments in the old monkey VSMC compared to the Young monkey reflecting extensive
cytoskeletal changes. Color bars index the cell height. Scale is given at the bottom. Reprinted from Zhu et al. (2012).
This dynamic behavior was altered in VSMC obtained from
aged (Figure 5) and hypertensive animals (Zhu et al., 2012;
Sehgel et al., 2013). This implies that dynamic mechanisms
governing cytoskeletal properties, such as molecular motors and
cytoskeletal polymerization/depolymerization, processes may be
involved in increasing VSMC stiffness. However, additional work
is required to fully understand these relationships. Altogether,
increased stiffness at the level of the VSMC is a novel feature
that appears to correlate with increased arterial stiffness. This
represents a new potential mechanism that requires further
consideration as a modulating factor contributing to arterial
stiffness.
Cell-matrix Interactions
Cells are physically integrated within the vascular wall through
adhesive interactions with tissue ECM involving integrins to
form focal adhesions and with each other through cadherins
that mediate cell-to-cell junctions. This part of the review will
focus on the adhesion sites with the ECM that form part of an
ECM-integrin-cytoskeletal axis that is responsive to the physical
environment surrounding the cells. These interactions form the
basis for a mechanical syncytium that contributes to regulation
of the intrinsic tone and stiffness properties of the cell and
vascular wall. VSMC are connected at multiple locations with the
ECM. VSMC adhesion to fibronectin (FN) have been reported
to be directly involved in mechanotranduction (Wang et al.,
1993; Choquet et al., 1997; Riveline et al., 2001; Sun et al.,
2008, 2012), and may underlie intrinsic myogenic tone in VSMC.
It has also been demonstrated that when VSMC are exposed
to vasoactive agonists that coordinated changes occur in the
cell stiffness and the adhesion to ECM proteins (Hong et al.,
2012, 2014, 2015). In addition, vasoactive agonists produce rapid
remodeling of the cytoskeleton that is linked to changes in
cell stiffness (Hong et al., 2014). This response may be related
to the contractile function of VSMC and the proposal that
transmission of generated force by VSMC to the ECM requires
generalized strengthening of adhesions. However, it is also well
documented that cells respond to stiffer ECM by becoming stiffer
(Solon et al., 2007). Collectively, these data indicate that cells
respond to both soluble factors and mechanical cues in their
immediate environment and that impact VSMC mechanical and
ECM adhesive properties. How these responses might also play
a role in chronically elevating VSMC stiffness as is observed in
cases of increased vascular stiffness remains to be determined,
but themechanisms that underlie these observationsmay provide
fruitful areas for further investigation.
That adhesion to the ECM may be significant is supported
by studies by Bezie et al. They have previously speculated that
integrins may play an important role in vascular stiffness in
hypertension. They observed an increase in the surface area on
the VSMC membrane occupied by dense plaques and reported
and increased expression of FN and α5 integrin in the aorta
of hypertensive models with increased aortic vascular stiffness
(Bezie et al., 1998a; Bézie et al., 1998b). Moreover, as we have
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FIGURE 5 | Example of a 30min records of cell elastic moduli for an old (A) and young (B) monkey VSMC. Blue line shows raw data and the red line displays
the reconstructed data after analysis. Data were processed using an eigendecomposition partition to permit the amplitude, frequency and phase components of the
oscillation to be separated on cell-by-cell basis. Averaged data for old VSMC (n = 24) and young (n = 27) show differences in dynamic oscillatory behavior of old and
young VSMC (C). Reprinted from Zhu et al. (2012).
previously noted (Sehgel et al., 2015), there are several reports of
increased presence of FN and α5 integrin in the vessels of several
hypertension models: SHR (Takasaki et al., 1990; Bezie et al.,
1998a; Intengan et al., 1999), deoxycorticosterone/salt (Takasaki
et al., 1990), angiotensin II-infusion (Takasaki et al., 1990), as well
as non-hypertensive vascular stiffness models (Bouissou et al.,
2014). Treatment with antihypertensive drugs has been reported
to decrease vascular FN levels currently with a decrease in arterial
stiffness (Koffi et al., 1998; Kakou et al., 2009). Morgan and
colleagues have previously hypothesized that focal adhesions are
a key regulator of vascular stiffness (Saphirstein et al., 2013;
Gao et al., 2014; Saphirstein and Morgan, 2014), demonstrating
an association between the modulation of cell contractility,
cell stiffness, and focal adhesion size of VSMC. Collectively,
these observations strongly suggest that alterations in the ECM
adhesive properties of VSMC may also be an important site
linked to changes in arterial stiffness.
We have recently reported increased adhesion to FN in VSMC
derived from aging and hypertensive models with increased
arterial stiffness (Qiu et al., 2010; Zhu et al., 2012; Sehgel et al.,
2015). This was detected by using AFM probes coated with
FN that were then brought into contact with the VSMC cell
membrane surface. Analysis of the interactions between the AFM
probe and the cell surface confirmed an increased adhesion of
the FN coated AFM probe to VSMC derived from aging and
hypertensive animals. We believe these measurements are among
the first to directly confirm using biophysical assessment tools
that increased attachment to FN does occur, and this property of
VSMC is modified in the aging and hypertensive models. These
observations further support the hypothesis that cell stiffness and
adhesion are linked andmay be important alternative therapeutic
targets for to explore for anti-hypertensive therapy as well as
anti-arterial stiffness therapy.
Endothelial Contributions
Endothelial mechanisms have also been proposed to contribute
to arterial stiffness, namely through endothelial dysfunction
leading to the decreased bioavailability of vasorelaxing factors
such as nitric oxide (NO), endothelial derived hyperpolarizing
factor and prostacyclin (Bellien et al., 2010; Sudano et al.,
2011). Other endothelial factors such as endothelin-1 and C-
type natriuretic peptide may also play a role (Vlachopoulos et al.,
2010). Collectively, endothelial cells secrete vasoactive factors
that function to regulate contractile tone in underlying VSMC.
As reviewed by Wilkinson and colleagues, several conditions
exhibiting endothelial dysfunction such as hypercholesterolemia
and diabetes are also associated with increased arterial stiffness
(Wilkinson et al., 2004). Arterial stiffness in patients has been
shown to increase upon systemic administration of endothelial
NO synthase inhibitors: L-NG-monomethyl arginine (LNMMA)
(Wilkinson et al., 2002) and N(G)-nitro-L-arginine methyl ester
(L-NAME) (McVeigh et al., 2001). As noted by Wilkinson
and colleagues, though these infusions produce other changes
in hemodynamics [e.g., increase in mean arterial pressure
(MAP)] that confound the measurement of arterial stiffness,
the contribution of NO has been validated by studies utilizing
local administrations of NO synthase inhibitors (Wilkinson et al.,
2004). Iliac artery stiffness was decreased and increased by local
administration of glyceryl trinitrate and LNMMA, respectively,
without any change inMAP (Schmitt et al., 2005). Similar studies
demonstrated an opposite role for increased endothelin-1 in
regulating vascular stiffness (McEniery et al., 2003).
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One interesting hypothesis has been advanced byOberleithner
and colleagues has been that aberrant endothelial signaling may
be the result of a mechanical stiffening of EC (Oberleithner,
2005; Fels et al., 2010, 2014; Kusche-Vihrog et al., 2015). The
increased stiffness of the EC was associated with modulation of
epithelial sodium channel (ENaC) activity and was associated
with a reduced ability of the EC to produce NO (Kusche-
Vihrog et al., 2010, 2014). This phenomenon has been
termed the “stiff endothelial cell syndrome,” and has been
speculated to characterize EC stress and thus contribute to
vascular disease (Lang, 2011). It is possible that the increased
stiffness of EC and subsequent reduction in production of
vasorelaxing factors may also play a role in increasing vascular
stiffness.
Inflammatory Mechanisms
Recently, the contributions of inflammatory mechanisms to
arterial stiffness have attracted interest. Several clinical studies
have established a link between increased arterial stiffness
independent of other cardiovascular disease risk factors in
patients with various inflammatory diseases, such as rheumatoid
arthritis (Klocke et al., 2003) and inflammatory bowel disease
(Korkmaz et al., 2014). Moreover, the higher arterial stiffness
is ameliorated after treatments to control the inflammation, as
shown by Zanoli and colleagues in patients with inflammatory
bowel disease (Zanoli et al., 2014). As summarized by Jain
and colleagues, in the short-term vascular stiffness may be
increased due to the disruption of EC NO metabolism in
inflammation, while in the long-term inflammation may lead
to increased arterial stiffness through changes in collagen and
elastin deposition and cross-linking (Jain et al., 2014). In
experimental studies of hypertension, increased arterial stiffness
has been shown to be mediated by T-cell mediated inflammation
(Barhoumi et al., 2011;Wu et al., 2014). Altogether, inflammation
also appears as a good candidate involved in altering vascular
stiffness through fundamental mechanisms related to ECM
modification, endothelial NO release and perhaps changes in
VSMC function.
REDEFINING THE STRUCTURAL BASIS OF
ARTERIAL STIFFNESS
As reviewed above, an increase in vascular stiffness can be
observed in hypertension in in the absence of increased collagen
content and decreased elastin content as the literature on this
point is not consistent. This indicates that there are other
operative mechanisms that require elucidation in the case of
increased vascular stiffness. Furthermore, it also suggests the
need to re-examine the temporal, structural andmechanical basis
of arterial stiffness at smaller lengths of scales.
It is intriguing to speculate that perhaps structural
explanations beyond changes in the ECM protein content
and type for arterial stiffness have not been forthcoming for
technical reasons. However, it is quite clear from the literature
that the mechanical properties of the ECM must be considered.
An appreciation for the pathophysiology of altered mechanical
properties of arteries was first noted by Roy in the nineteenth
century (Roy, 1881). After this, further recognition grew in the
latter half of the twentieth century, and corresponded with the
development of advanced measurement and analysis techniques
(Nichols et al., 2005). Coincidently, during this period there
were also a host of notable studies of arterial structure and
geometry that provided detailed assessments and quantification
of collagen and elastin within the arterial wall (Harkness et al.,
1957; Wolinsky and Glagov, 1964; Fischer and Llaurado, 1966).
In addition, it was determined that the elastic modulus of
collagen is significantly greater than that of elastin (Dobrin
and Canfield, 1984; Armentano et al., 1991). As recognized by
Nichols and O’Rourke, when coupled with observations that the
increase in the ratio of collagen-to-elastin down the arterial tree
(Harkness et al., 1957) correlated with the increase in pulse wave
velocity down the arterial tree (Nichols and McDonald, 1972), it
became very plausible to suggest the hypothesis that an increase
in collagen with a concurrent decrease in elastin was responsible
for increased arterial stiffness.
By extension, this structural mechanism has been applied to
explain the increased arterial stiffness present in hypertension
FIGURE 6 | Increases arterial stiffness develops from both extracellular (ECM) and cellular mechanisms.
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and this notion has persisted despite numerous controversial
reports that do not necessarily support the proposed
directionality of changes in collagen and elastin content in
hypertension. Cox was one of the first to suggest that intrinsic
differences in the mechanical properties of smooth muscle may
be responsible for arterial stiffness. He based this conclusion
on the finding of no innate difference in collagen and elastin
coupled with the presence of increased stress development by
vasoactive stimulation in hypertensive smooth muscle even
after normalized to the smooth muscle content area (Cox,
1981). Despite knowledge that vasoregulatory agents can raise
and lower vessel wall stiffness by modulation of VSMC tone,
no consideration was given to idea that innate mechanical
properties of VSMC (i.e., in an unstimulated or “passive”
state) may be contributing to wall stiffness. In addition, little
consideration was given to the possibility that adhesive coupling
of the VSMC within the wall might be important. Such detailed
study of cell mechanics have been hampered by the absence of
adequate technologies for studies of the mechanical properties
of single cells and molecules (e.g., AFM, magnetic bead twisting
cytometry, micropipette aspiration, optical tweezers) that have
only occurred in the last 50 years. The potential importance of
mechanical contributions of VSMC to arterial stiffness has only
recently been supported following the application of AFM to
directly measure stiffness and adhesion in VSMC (Qiu et al.,
2010; Zhu et al., 2012; Sehgel et al., 2013, 2015). However, this
isolated cell data must ultimately be confirmed in the intact tissue
and place into an integrated model of overall arterial wall tissue
mechanics. It is clear that isolated cell mechanics are strongly
influenced by the stiffness and type of underlying ECM substrate
on which cells are grown. Also, isolating and placing cells in
a culture environment can induce changes in cell phenotype.
These facts underscore the need to continue to develop new
model approaches to refine our understanding of how VSMC are
affected by their surrounding ECM and mechanical environment
and how VSMC contribute to the stiffness of the intact tissue.
Continued development of appropriate methodologies, models
and approaches will be required to fully address these issues.
However, at this point, we would suggest that the determinants
of increased arterial stiffness should be expanded to include
the possible contributions of both extracellular and cellular
mechanisms (Figure 6).
INTRODUCING THE “SMOOTH MUSCLE
CELL STIFFNESS SYNDROME” (SMCSS)
The introduction of “Stiff Cell Syndrome” with respect to
EC (Lang, 2011) and our recent findings for VSMC lead us
to extend the concept of “Stiff Cell Syndrome” to include
VSMC. This syndrome with respect to VSMC includes altered
cellular mechanical and adhesive properties of the VSMC.
It appears to involve cytoskeletal changes, focal adhesion
changes and will perhaps be shown to involve cell-cell
adhesion properties as well. Recognition that a smooth muscle
cell stiffness syndrome may accompany increases in arterial
stiffness opens up a variety of new investigative possibilities
to improve our understanding of the mechanisms driving
FIGURE 7 | Smooth muscle stiffness syndrome (SMCSS) is characteristic of increased arterial stiffness. SMCSS describes the aberrant increased cortical
stiffness and adhesion to fibronectin (FN) observed in vascular smooth muscle cells derived from stiff vessels. SMCSS may be an important therapeutic target for
direct modulation of arterial stiffness.
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and underlying changes in arterial stiffness (Figure 7). We
propose that stiffening of vascular cells importantly affects cell
level functions, which in turn alters vascular functional and
mechanical properties. As such, increased cell stiffness should
be considered as part of the complex of changes observed in
vascular stiffening that is observed in aging and cardiovascular
disease.
CONCLUSION
In conclusion we would suggest the presence of alternative
mechanisms, rather than only changes in the ECM, as
contributors to increased arterial stiffness. We introduce
the concept of smooth muscle cell stiffness syndrome, to
incorporate new information that increases in vascular stiffness
are accompanied by increases in the stiffness and adhesiveness
of VSMC at the cellular level. Importantly, modulation of these
cellular mechanisms may be an opportunistic target toward
the development of novel pharmacological therapeutics for
hypertension and arterial stiffness.
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